CoQ10 / Ubiquinol

The mitochondrial active that bridges heart, healthy aging, and statin support.

Coenzyme Q10 is a lipid-soluble compound essential to mitochondrial energy production. Ubiquinol is the reduced (active) form that absorbs better than the older ubiquinone, particularly in adults over 40. Strong evidence in heart failure, statin-related muscle symptoms, and healthy aging positioning.

Coenzyme Q10 is one of the foundational mitochondrial nutrients. A lipid-soluble quinone that sits in the electron transport chain and is essential for ATP production. The body makes its own, but endogenous synthesis declines with age (sharply after 40), and statin medications further suppress production. That demographic and pharmacologic setup is what makes CoQ10 a category with durable demand: older adults, statin users, and anyone interested in mitochondrial-health positioning.

The formulation conversation now centers on form. CoQ10 exists in two redox states: ubiquinone (oxidized, the older form) and ubiquinol (reduced, the form actually used in mitochondria). Multiple head-to-head trials show ubiquinol absorbs better than ubiquinone, particularly in adults over 60 and in those with absorption challenges. Ubiquinone costs less per milligram; ubiquinol carries a 2–4× raw-material premium but supports better claim language and absorbs at lower per-serving doses. For premium and healthy-aging positioning, ubiquinol is the right call. For mass-channel and budget tiers, ubiquinone with a co-formulated oil base (softgels are still the dominant format) still works.

The two best-evidence positioning angles are statin-associated muscle symptoms (the Q-SYMBIO and follow-on trials remain widely cited) and heart-failure adjunctive support (a recognized clinical use in some European guidelines). Healthy-aging and energy positioning rest on weaker direct outcome evidence but reasonable mechanism plausibility.

Why Brands Choose CoQ10 / Ubiquinol

Demographic tailwind

Endogenous CoQ10 declines with age. The supplement category grows naturally with the over-50 population, independent of trend cycles.

Statin co-prescription opportunity

Roughly 1 in 4 adults over 40 takes a statin. Many cardiologists co-recommend CoQ10 for muscle-symptom support. A meaningful HCP-referral channel.

Strong clinical positioning in heart and mitochondrial categories

Q-SYMBIO heart failure trial and the broader mitochondrial-aging literature support credible premium positioning.

Formulation Notes

Working with CoQ10 / Ubiquinol

  • Ubiquinol dose: 100–200 mg/day. Ubiquinone dose: 200–400 mg/day (lower absorption requires higher dose).
  • CoQ10 is lipid-soluble. Take with a fat-containing meal. Softgel formats with an oil base outperform powder capsules on absorption.
  • Ubiquinol is oxidatively unstable and must be packed in oxygen-restricted softgel manufacturing. Specify Kaneka KH (the dominant clinical-grade ubiquinol source) or equivalent.
  • Pair with omega-3, magnesium, and B-vitamins in cardiovascular-support formulas.
  • Bright yellow color. Stains light-colored packaging and is challenging in clear gel caps without protection.

Dosage Guidance

Ubiquinol: 100–200 mg/day with food. Ubiquinone: 200–400 mg/day with food. Higher doses (300–600 mg ubiquinol) are used in heart-failure protocols.

Delivery Forms

SoftgelLiquidCapsuleChewable tablet

Considerations

  • Some interaction risk with anticoagulants (warfarin). Required label warnings vary by jurisdiction.
  • Ubiquinol can revert to ubiquinone during manufacturing if not protected. Specify oxygen-restricted production for ubiquinol products.
  • Pricing pressure on ubiquinone has compressed margins at commodity tiers. Ubiquinol is where the profitable positioning lives.

Regulatory Status

Canada (NPN)

Ubiquinone and ubiquinol are both covered by Health Canada monographs with defined dose ranges and supported claim language. NPN submission is a standard path.

USA (DSHEA)

Both forms are established dietary ingredients under DSHEA. Structure-function claims for cardiovascular and energy support are common. Avoid disease-treatment language regarding heart failure or statin myopathy.

Common Structure-Function Claims

  • Helps support cardiovascular health
  • Supports energy production at the cellular level
  • Provides antioxidant support
  • Helps maintain CoQ10 levels often depleted by statin medications

Claim language must be reviewed for your specific product and market before use. Not all claims are permitted in every jurisdiction.

Clinical Evidence & Market Demand

Selected peer-reviewed studies, plus the demand signals we're seeing from founders, retailers, and consumer search behaviour.

Primary literature

Market & consumer demand

CoQ10 maintains stable retail sales in the top 10 supplement actives by dollar volume, with ubiquinol formats taking share from ubiquinone year over year.

CoQ10 isn't a viral category, but it has one of the most durable demand profiles in supplements. The buyer is typically a 45-and-older adult, often statin-prescribed, who has been recommended CoQ10 by their cardiologist or pharmacist. That HCP-referral channel makes the category unusually stable through trend cycles. The growth lever now is the form transition: brands launching new SKUs are skipping ubiquinone and going straight to ubiquinol, which both improves their absorption story and supports a 30–50% retail price premium.

  • Examine.com: Coenzyme Q10: Strongest evidence for heart failure outcomes and statin-related muscle symptoms. Moderate for blood pressure, weaker for athletic performance.
  • International Coenzyme Q10 Association: Industry body that organizes the clinical research conference and publishes consensus documents on CoQ10 use.

References are provided for educational purposes. Citations do not constitute medical claims or guarantee outcomes. Structure-function claim language must be reviewed for your specific product and market.

Related Services

Custom formulation and R&D

Our formulators build your product from scratch. Most custom formulas take 8–12 weeks to develop, and you own 100% of the IP when it's done.

Manufacturing coordination

Start with as few as 1,000 units. We've vetted every facility in our network for GMP compliance, on-time delivery, and consistent quality.

Related Ingredients

Omega-3 (EPA/DHA)

EPA and DHA from marine sources are still the default omega-3 ingredients, with one of the deepest clinical files in the supplement industry. Brands differentiate on sourcing, concentration, and freshness more than on the ingredient itself.

NMN (Nicotinamide Mononucleotide)

NMN is the most-discussed NAD+ precursor in longevity wellness, with real founder and consumer interest on both sides of the border. Before anyone ships an NMN product, the regulatory status in the US and Canada needs a current review. The rules here have changed recently and are still in motion.

Curcumin (Bioavailable)

Curcumin is the principal active in turmeric and one of the most-researched anti-inflammatory botanicals available. Unformulated curcumin has poor oral absorption, so the formulation conversation is really about which bioavailable form you're using.

Ready to build with CoQ10 / Ubiquinol?

Tell us about your product concept and we'll put together a formulation, sourcing, and manufacturing plan tailored to your brand, format, and market.

Get a Free QuoteView All Ingredients